glp 1 with nad Huff's Glucagon-Like Peptide-1 Based Therapies: A

All of these GLP-1 effects (Figure 2) are potentially beneficial for patients with T2D, and have been sought exploited clinically with the development of GLP-1R agonists

10.1111/j.1742-1241.2010.02353.x 27

Making informed decisions about your health is paramount

Topical retinoids can potentially provide very low levels of collagen, more efficient modalities include lasers, RF microneedling (correct depth & settings) as well as HIFU & biostimulatory injectables

Additionally, semaglutide is not recommended for individuals with type 1 diabetes or diabetic ketoacidosis, as it is specifically designed for managing type 2 diabetes

Further research, including controlled studies with proper single-compound comparison groups, is needed to validate any combined effect